Surge in Metabolic and Bariatric Surgery Amid Rise of GLP-1 Receptor Agonists
In a groundbreaking shift within metabolic and bariatric treatment paradigms, recent national data reveal a dramatic rise in prescriptions for semaglutide and tirzepatide among patients...
















